Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Demonstration of 23-Gene Expression Profile Test Utility Within PRAME Immunohistochemistry Results: A Case Series.

The American Journal of dermatopathology·2026

Same author

Subclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular Tumors.

bioRxiv : the preprint server for biology·2026

Same author

Role of POU4F3 in the Diagnosis of Cutaneous Follicular Tumors.

Journal of cutaneous pathology·2026

Same author

Acquired Elastotic Hemangioma With Smooth Muscle Hypertrophy: A Case Report and Brief Review of the Literature.

Journal of cutaneous pathology·2026

Same author

Cutaneous Crystal-Storing Histiocytosis With Marginal Zone Lymphoma. A Case Report With A Striking Clinical Presentation.

Journal of cutaneous pathology·2026

Same author

Proteomics and single-cell transcriptomics identify LRP1 as a diagnostic biomarker for atypical fibroxanthoma and pleomorphic dermal sarcoma.

bioRxiv : the preprint server for biology·2026

Search research articles

Related Experiment Video

Updated: Jul 30, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Ancillary testing for melanoma: current trends and practical considerations.

Gregory A Hosler¹, Kathleen M Murphy²

¹ProPath, Dallas, TX, 75247, USA; University of Texas Southwestern, Departments of Dermatology and Pathology, Dallas, TX, 75390, USA.

Human Pathology

|May 13, 2023

Summary

Diagnosing melanocytic lesions often relies on clinical and histomorphological assessment. Ancillary tests like immunohistochemistry and molecular studies can aid in borderline cases, but should be used cautiously.

Keywords:

Ancillary testing Immunohistochemistry Melanocytic Melanoma Molecular Practical considerations

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Related Experiment Videos

Last Updated: Jul 30, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Area of Science:

Dermatopathology
Oncology
Molecular Diagnostics

Background:

Melanocytic lesions require accurate diagnosis, often relying on histomorphological assessment.
Ancillary tests can supplement diagnosis but are not always necessary.
Borderline lesions pose diagnostic challenges.

Purpose of the Study:

To review current ancillary tests for characterizing melanocytic lesions.
To discuss scientific and practical considerations for test selection.
To evaluate the role of immunohistochemistry and molecular studies.

Main Methods:

Literature review of ancillary diagnostic tests for melanocytic lesions.
Analysis of test performance, technology, and practical factors.
Discussion of stepwise testing strategies.

Main Results:

Clinical and histomorphological assessment are sufficient for most melanocytic lesions.
Immunohistochemistry and molecular studies help refine diagnoses of borderline lesions.
Test selection depends on diagnostic questions, cost, and turnaround time.

Conclusions:

Ancillary tests are valuable adjuncts for specific melanocytic lesion diagnoses.
A stepwise approach to ancillary testing is recommended when utilized.
Balancing scientific evidence with practical constraints is crucial for effective test selection.